
No results matched your search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
PFE | NYSE | USD | Real-time | |
PFE | Mexico | MXN | Delayed | |
PFE | Stockholm | SEK | Delayed | |
PFIZ | NSE | INR | Real-time | |
PFIZ | BSE | INR | Real-time | |
PFE | Hamburg | EUR | Delayed | |
PFE | Xetra | EUR | Delayed | |
PFE | Frankfurt | EUR | Delayed | |
PFE | TradeGate | EUR | Delayed | |
PFE | Santiago | USD | Delayed | |
PFE | Buenos Aires | ARS | Delayed | |
PFIZ34 | BM&FBovespa | BRL | Delayed | |
PFE | Vienna | EUR | Delayed | |
PFE-RM | Moscow | RUB | Real-time | |
US_PFE | KASE | KZT | Delayed | |
PFE | Lima | USD | Delayed |
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 3) Aerie Pharmaceuticals, Inc....
The FDA has approved Pfizer Inc's (NYSE: PFE) supplemental application seeking approval for Lorbrena (lorlatinib), expanding the indication to include first-line treatment of...
The FDA has approved Pfizer's (PFE) supplemental New Drug Application (sNDA) for Lorbrena(lorlatinib), expanding the indication to include first-line treatment of people with...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Neutral | Neutral | Sell | Sell | Sell |
Technical Indicators | BUY | Strong Sell | Sell | Sell | Strong Sell |
Summary | Neutral | Sell | Sell | Sell | Strong Sell |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Emerging Patterns | |||||
Falling Three Methods | 15 | Current | |||
Three Black Crows | 1M | Current | |||
Completed Patterns | |||||
Three Outside Up | 15 | 1 | Mar 04, 2021 20:15 | ||
Three Stars in the South | 1W | 2 | Feb 14, 2021 | ||
Three Outside Up | 5H | 2 | Mar 03, 2021 20:00 |
Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
---|---|---|---|---|---|---|---|---|---|
NYSE | 33.97 | 33.96 | 33.97 | 33,077,798 | -1.22% | USD | 20:38:32 | ||
Mexico | 720.00 | 713.01 | 722.99 | 1,413 | +0.28% | MXN | 20:18:48 | ||
Stockholm | 292.0 | 0.0 | 0.0 | 23,126 | +2.46% | SEK | 18:00:00 | ||
NSE | 4,612.85 | 0.00 | 0.00 | 41,956 | -0.69% | INR | 10:59:48 | ||
BSE | 4,592.00 | 0.00 | 0.00 | 4,702 | -1.19% | INR | 10:59:51 | ||
Hamburg | 28.88 | 0.00 | 0.00 | 512 | +2.87% | EUR | 17:13:00 | ||
Xetra | 28.810 | 28.850 | 28.880 | 122,820 | +2.71% | EUR | 17:35:00 | ||
Frankfurt | 28.60 | 0.00 | 0.00 | 10,278 | +1.04% | EUR | 19:20:00 | ||
TradeGate | 28.40 | 28.36 | 28.39 | 116,377 | -0.40% | EUR | 20:37:00 | ||
Santiago | 34.78 | 0.00 | 0.00 | 430 | 0.00% | USD | 16/02 | ||
Buenos Aires | 2,581.00 | 2,581.00 | 2,614.50 | 4,413 | -0.67% | ARS | 20:18:00 | ||
BM&FBovespa | 48.30 | 48.28 | 48.40 | 59,208 | -0.25% | BRL | 20:21:00 | ||
Vienna | 30.400 | 0.000 | 0.000 | 1,574 | -1.30% | EUR | 21/12 | ||
Moscow | 2,561.00 | 2,561.00 | 2,561.00 | 6,993 | +0.51% | RUB | 16:58:42 | ||
KASE | 0.00 | 0.00 | 0.00 | 0 | 0.00% | KZT | 30/11 | ||
Lima | 0.00 | 0.00 | 0.00 | 0 | 0.00% | USD | 30/11 |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
MTN Nigeria | 162.00 | 162.00 | 162.00 | -8.00 | -4.71% | 599.06K | 14:30:00 | ||
FBN Holdings | 7.05 | 7.10 | 6.75 | -0.05 | -0.70% | 31.25M | 14:30:00 | ||
Guaranty Trust Bank | 31.50 | 31.80 | 31.05 | -0.20 | -0.63% | 15.50M | 14:30:00 | ||
Zenith Bank | 25.30 | 25.65 | 25.30 | -0.25 | -0.98% | 38.65M | 14:30:00 | ||
UBA | 7.95 | 8.15 | 7.75 | -0.30 | -3.64% | 26.78M | 14:30:00 | ||
Access Bank | 7.80 | 8.05 | 7.70 | -0.25 | -3.11% | 21.59M | 14:30:00 | ||
Dangote Cement | 198.00 | 198.00 | 198.00 | -22.00 | -10.00% | 1.18M | 14:19:00 | ||
Dangote Flour Mills | 22.25 | 22.30 | 22.25 | 0.00 | 0.00% | 0 | 04/02 | ||
Dangote Sugar | 16.55 | 17.45 | 16.50 | -1.10 | -6.25% | 12.47M | 14:30:00 | ||
Japaul Gold Ventures | 0.50 | 0.53 | 0.49 | -0.01 | -1.85% | 14.44M | 14:18:00 |
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review